← Leaderboards
Alexander James Bishop
University Of Texas Hlth Sci Ctr San Ant
$4,634,367
Attributed
$4,634,367
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $483K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,634,367 · 4
By mechanism
R01$3,867,405 · 2
R15$445,500 · 1
K22$321,462 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Patrick Sung$43,318,700
- Yousin Suh$23,055,406
Others in their field
Top investigators on “Rna Interference”
- Norbert Perrimon · Harvard Medical School$46,131,269
- Stuart L Schreiber · Harvard University (Medical School)$43,040,912
- Gary B. Ruvkun · Massachusetts General Hospital$32,268,648
- Scott W Lowe · Sloan-Kettering Inst Can Research$27,556,396
- Judy Lieberman · Boston Children'S Hospital$25,876,315
- Ehud Isacoff · University Of California Berkeley$25,475,182
Research focus
Rna InterferencePathway InteractionsGenomicsResponseDna DamageGenesGenome-WideMalignant NeoplasmsFitnessCellsFli1 GeneEwings SarcomaYoung AdultChildhoodData AnalysesProteinsBiologyInterestInsightMonitorCell TypeBaseDefectCell Cycle Progression
Grant awards (18)
Dysregulated transcription processes in Ewing sarcoma$291,262
R01 · FY2025 · CA · contact PI
Dysregulated transcription processes in Ewing sarcoma$394,343
R01 · FY2024 · CA · contact PI
Dysregulated transcription processes in Ewing sarcoma$61,608
R01 · FY2024 · CA · contact PI
Dysregulated transcription processes in Ewing sarcoma$418,143
R01 · FY2023 · CA · contact PI
Dysregulated transcription processes in Ewing sarcoma$64,850
R01 · FY2023 · CA · contact PI
Dysregulated transcription processes in Ewing sarcoma$160,818
R01 · FY2022 · CA · contact PI
Dysregulated transcription processes in Ewing sarcoma:$59,988
R01 · FY2022 · CA · contact PI
Dysregulated transcription processes in Ewing sarcoma$442,461
R01 · FY2021 · CA · contact PI
Dysregulated transcription processes in Ewing sarcoma$443,137
R01 · FY2020 · CA · contact PI
Improving etoposide treatment of Ewing's sarcoma$309,653
R01 · FY2015 · CA · contact PI
Improving etoposide treatment of Ewing's sarcoma$300,377
R01 · FY2014 · CA · contact PI
Improving etoposide treatment of Ewing's sarcoma$291,101
R01 · FY2013 · CA · contact PI
Improving etoposide treatment of Ewing's sarcoma$314,902
R01 · FY2012 · CA · contact PI
Improving etoposide treatment of Ewing's sarcoma$314,762
R01 · FY2011 · CA · contact PI
Comparing and contrasting the biology of damage survival at a genomic level$445,500
R15 · FY2010 · ES · contact PI
A screen for damage response genes using recombination$105,462
K22 · FY2006 · ES · contact PI
A screen for damage response genes using recombination$108,000
K22 · FY2005 · ES
A screen for damage response genes using recombination$108,000
K22 · FY2004 · ES